Title  |
Author |
Type |
Words |
| A breakthrough in the relief of overactive bladder and urinary incontinence. |
Faloon, William |
Clinical report |
3683 |
| A potential paradox in prostate adenocarcinoma progression: oestrogen as the initiating driver. |
|
Clinical report |
280 |
| Anti-inflammatory agents and antioxidants as a possible "third great wave" in cardiovascular secondary prevention. |
|
Clinical report |
273 |
| Apple stem cells offer hope for aging and damaged skin. |
Goldfaden, Gary |
Clinical report |
1924 |
| Association of lipoprotein-associated phospholipase A2 with coronary calcification among American and Japanese men. |
|
Clinical report |
272 |
| Brain food. |
Dye, Dayna |
Brief article |
168 |
| Broccoli reduces prostate cancer risk. |
Kiefer, Dale |
Clinical report |
207 |
| Calorie restriction decreases oxidative stress, increases life span. |
Kiefer, Dale |
Brief article |
196 |
| Catechol quinones of estrogens in the initiation of breast, prostate, and other human cancers: keynote lecture. |
|
Clinical report |
341 |
| Chondrogenesis from immortalized human mesenchymal stem cells: comparison between collagen gel and pellet culture methods. |
|
Brief article |
158 |
| Common spices help inhibit AGE. |
Dye, Dayna |
Brief article |
191 |
| Current antiplatelet therapies: benefits and limitations. |
|
Brief article |
97 |
| Dangers of excess estrogen in the aging male. |
Faloon, William |
Clinical report |
7095 |
| Detect your risk of sudden heart attack and stroke. |
Barclay, Laurie |
Clinical report |
4077 |
| Dietary approach to attenuate oxidative stress, hypertension, and inflammation in the cardiovascular system. |
|
Brief article |
264 |
| Disease-specific induced pluripotent stem cells. |
|
Brief article |
137 |
| Endogenous sex hormones and C-reactive protein in healthy postmenopausal women. |
|
Clinical report |
296 |
| Enhanced expression of LP-PLA2 and lysophosphatidylcholine in symptomatic carotid atherosclerotic plaques. |
|
Clinical report |
291 |
| Estradiol in elderly men. |
|
Clinical report |
299 |
| Estradiol, testosterone, and the risk for hip fractures in elderly men from the Framingham study. |
|
Clinical report |
373 |
| Estrogens and bone health in men. |
|
Brief article |
292 |
| Estrogens and vascular thrombosis. |
|
Clinical report |
291 |
| High omega-3 diet linked with lower heart disease risk. |
Dye, Dayna |
Clinical report |
177 |
| Higher plasma vitamin C levels linked with reduced diabetes risk. |
Dye, Dayna |
Clinical report |
181 |
| Human cloning and stem cell research: engaging in the political process. (legislation review: prohibition of human cloning act 2002 and the research involving human embryos act). |
|
Brief article |
156 |
| Identifying the vulnerable patient with rupture-prone plaque. |
|
Clinical report |
269 |
| Important functions of estrogens in men--breakthrough in contemporary medicine. |
|
Clinical report |
325 |
| In vitro generation of a scaffold-free tissue-engineered construct (TEC) derived from human synovial mesenchymal stem cells: biological and mechanical properties, and further chondrogenic potential. |
|
Clinical report |
183 |
| Induced pluripotent stem cells generated from patients with als can be differentiated into motor neurons. |
|
Brief article |
127 |
| Lipoprotein-associated phospholipase A2 and risk of stroke. |
|
Clinical report |
242 |
| Lipoprotein-associated phospholipase A2 is an independent predictor of incident coronary heart disease in an apparently healthy older population: the rancho bernardo study. |
|
Brief article |
260 |
| Lipoprotein-associated phospholipase A2 predicts progression of cardiac allograft vasculopathy and increased risk of cardiovascular events in heart transplant patients. |
|
Brief article |
304 |
| Lipoprotein-associated phospholipase A2, high-sensitivity C-reactive protein, and risk for incident ischemic stroke in middle-aged men and women in the atherosclerosis risk in communities (ARIC) study. |
|
Clinical report |
277 |
| Lipoprotein-associated phospholipase A2: A risk marker or a risk factor? |
|
Clinical report |
133 |
| Lipoprotein-associated phospholipase A2: an independent predictor of coronary artery disease events in primary and secondary prevention. |
|
Clinical report |
293 |
| Low serum testosterone and high serum estradiol associate with lower extremity peripheral arterial disease in elderly men. the MrOS study in Sweden. |
|
Clinical report |
275 |
| Lycopene lowers lipids, slows accumulation of atherosclerotic plaque. |
Ninger, Laura J. |
Clinical report |
194 |
| Marrow cell therapies for cardiovascular diseases. |
|
Brief article |
99 |
| Nutrient combination improves memory and learning. |
Hall, Michael J. |
Clinical report |
199 |
| Paraoxonases and cardiovascular diseases: pharmacological and nutritional influences. |
|
Brief article |
269 |
| Pomegranate extract inhibits inflammation. |
Ninger, Laura J. |
Clinical report |
199 |
| Poor vitamin D status linked with greater eight-year mortality risk. |
Dye, Dayna |
Clinical report |
161 |
| Preventing cardiovascular disease naturally. |
Goepp, Julius |
Clinical report |
5956 |
| Receptor for advanced glycation end products: fundamental roles in the inflammatory response: winding the way to the pathogenesis of endothelial dysfunction and atherosclerosis. |
|
Brief article |
193 |
| Regenerative medicine breakthroughs: will BioTime reset the clock of aging? |
Goepp, Julius |
Cover story |
5151 |
| Regulation of smooth muscle cells in development and vascular disease: current therapeutic strategies. |
|
Brief article |
158 |
| Resveratrol slows aging in mice. |
Ninger, Laura J. |
Clinical report |
170 |
| Serum estradiol and risk of stroke in elderly men. |
|
Clinical report |
245 |
| Soy isoflavones, curcumin synergize to thwart pancreatic cancer. |
Kiefer, Dale |
Brief article |
180 |
| Statins and peripheral arterial disease: effects on claudication, disease progression, and prevention of cardiovascular events. |
|
Clinical report |
198 |
| Statins for the primary prevention of cardiovascular events in older adults: a review of the evidence. |
|
Clinical report |
278 |
| Stem cell research: cloning, therapy and scientific fraud. |
|
Report |
107 |
| Stem cell treatment in amyotrophic lateral sclerosis. |
|
Brief article |
216 |
| Stem-cell based therapies for brain tumors. |
|
Clinical report |
125 |
| The molecular basis of vulnerable plaque: potential therapeutic role for immunomodulation. |
|
Clinical report |
194 |
| The problem of deception in embryonic stem cell research. |
|
Brief article |
99 |
| The role of estrogens and estrogen receptors in normal prostate growth and disease. |
|
Brief article |
98 |
| The significance of low HDL-cholesterol levels in an ageing society at increased risk for cardiovascular disease. |
|
Brief article |
196 |
| Variability in response to cardiovascular drugs. |
|
Brief article |
125 |
| Wonder drugs may treat many conditions. |
Dye, Dayna |
Clinical report |
159 |
